Vineet Bhandari
Elsevier Science
e druk, 2020
9780128189870
Tantalizing Therapeutics in Bronchopulmonary Dysplasia
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2020
ISBN13: 9780128189870
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Tantalizing Therapeutics in Bronchopulmonary Dysplasia is a concise reference that provides an overview of emerging concepts in the understanding of lung development and injury from a molecular and cellular point-of-view, including exciting pathways that are paving the way for new options to prevent or treat Bronchopulmonary Dysplasia (BPD). The book's chapters are written by experts who are at the forefront of BPD research. Coverage includes chapters on exosomes, stem cells and miRs, as well as a section on new discoveries in BPD research with translational potential. This is a must-have reference for researchers, physicians and trainees working on BPD, lung developmental biology, and more.
Specificaties
Inhoudsopgave
<p>Section 1: Current Therapeutics: State of the Art</p> <p>1. Systemic and topical glucocorticoids to prevent BPD</p> <p>Kristi Watterberg and Olivier Baud</p> <p>2. Use of caffeine for prevention of BPD</p> <p>Abhay Lodha, Stefani Doucette, and Vineet Bhandari</p> <p>3. Next Generation ventilator strategies to prevent/manage BPD</p> <p>Martin Keszler and Ashish Gupta</p> <p>Section 2: Ongoing Therapeutic Studies with Translational Potential</p> <p>4. End points for therapeutic trials for BPD: lessons learned from clinical trials</p> <p>Judy L. Aschner and Cynthia T. McEvoy</p> <p>5. What can exogenous surfactant provide in the fight against BPD?</p> <p>Peter A. Dargaville</p> <p>6. Stem cells in the treatment of BPD</p> <p>So Yoon Ahn, Yun Sil Chang, Won Soon Park</p> <p>Section 3: Future Therapeutic Directions</p> <p>7. Extracellular vesicles in the therapy of BPD</p> <p>Flore Lesage and Bernard Thebaud</p> <p>8. Growth factors in the therapy of BPD</p> <p>Heber C. Nielsen, Anne Chetty, and Vineet Bhandari</p> <p>9. Antenatal approaches in the therapy of BPD</p> <ol></ol> <p>Andre Gie, Ignacio Valenzuela, Thomas Salaets, Jan Deprest, and Jaan Toelen</p> <p>10. miRs –mere hype or master regulators in the therapy of BPD?</p> <ol></ol> <p>Charitharth Vivek Lal, Vivek Shukla, Namasivayam Ambalavanan, and Vineet Bhandari</p> <p>11. Immune modulators for the therapy of BPD</p> <p>Margaret Gilfillan and Vineet Bhandari</p>